Thermo Fisher Scientific Q2 2026 Earnings Preview
Seeking Alpha ·
Thermo Fisher Scientific ( TMO ) is scheduled to announce Q2 earnings results on Thursday, July 23rd, before market open. The consensus EPS estimate is $5.71 (+6.5% Y/Y) and the consensus revenue estimate is $11.7B (+7.7% Y/Y).
AI 시장 분석
Thermo Fisher Scientific is scheduled to report its Q2 2026 earnings before the market opens on July 23. Market consensus estimates earnings per share of $5.71, up 6.5% year-over-year, and revenue of $11.7 billion, an increase of 7.7%. This earnings release is expected to be a major turning point in gauging the overall demand recovery in the healthcare and life sciences sectors. Investors should focus on whether expectations are met along with the guidance for the second half of the year.
상승 영향
- Biotech — Achieving the expected revenue of $11.7 billion and EPS of $5.71 will drive a recovery in R&D investments, significantly increasing demand for pharmaceutical and life sciences equipment.
AI가 생성한 분석으로 투자 자문이 아닙니다.
DYAX Investor Sentiment
Bullish (Long) 73% · Bearish (Short) 27%
402 participants
Related News
- Norwood outlines a 3-year AI rollout plan as tangible book value per share returns above $22.90 post-acquisition
- Kratsios says Moonshot built Kimi K3 through 'industrial distillation' of Anthropic's Fable
- Equity ETFs dominate again as $140B in positive flows funnel into funds in June
- AI investments are starting to pay off – JPMorgan’s Stephen Parker
- Intel earnings setup: Options market prices in double-digit move
- Revolut hits $115 billion valuation in employee share sale
